Rare Disease Specialty Pharmacy Centers of Excellence Report

$249.00

Rare diseases are classified as any disease that affects less than 200,000 Americans. Orphan diseases, including rare diseases, are neglected conditions whose treatments are often not considered profitable due to their cost to develop and limited patient population.

Specialty pharmacies play a crucial role in the management of rare diseases, offering specialized services and support tailored to the unique needs of patients facing these conditions.

Centers of Excellence (CoE) were designed to improve the reach of critical expertise throughout the organization, regardless of geographical location or business unit. Specialty pharmacy CoEs are most often developed for therapies and disease states to create value in specific areas of clinical expertise.

The Rare Disease Specialty Pharmacy Centers of Excellence Report offers comprehensive intelligence on over 30 specialty pharmacies that offer Centers of Excellence to treat rare disease patients. The report provides a profile for each pharmacy that includes: company background, strategy, top executives, financial/investor information, products and services, and recent activities.

 

The new Report is available for $249 for a single-user license. Department and Corporate Licenses are available, please click here.